Vaidya Sane Ayurved Laboratories Stock Screener | Share Price & Fundamental Analysis
MADHAVBAUG
Medical Equipment
Screen Vaidya Sane Ayurved Laboratories share price with our stock screener - analyze fundamentals and track trades in your journal
Market Cap
₹298.58 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
4.81
EPS (TTM)
₹1.88
Dividend Yield
-
Debt to Equity
0.02
52W High
-
52W Low
-
Operating Margin
5.00%
Profit Margin
4.54%
Revenue (TTM)
₹5,173.00
EBITDA
₹332.00
Net Income
₹235.00
Total Assets
₹71.00
Total Equity
₹56.00
Vaidya Sane Ayurved Laboratories Share Price History - Stock Screener Chart
Screen MADHAVBAUG historical share price movements with interactive charts. Analyze price trends and patterns.
Vaidya Sane Ayurved Laboratories Company Profile - Fundamental Screener
Screen Vaidya Sane Ayurved Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for MADHAVBAUG shares.
Sector
Healthcare
Industry
Medical Equipment
Sub-Sector
Medical Equipment
Segment
E
ISIN
INE0JR301013
Vaidya Sane Ayurved Laboratories Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen MADHAVBAUG balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2024 | 2023 |
|---|---|---|
| Assets | ||
| Total Assets | 71 | 55 |
| Current Assets | 34 | 28 |
| Fixed Assets | 28 | 21 |
| Liabilities | ||
| Total Liabilities | 71 | 55 |
| Current Liabilities | 1 | 2 |
| Non-Current Liabilities | 0 | 0 |
| Shareholders' Equity | ||
| Total Equity | 56 | 41 |
| Share Capital | 11 | 11 |
| Reserves & Surplus | 32 | 30 |
Vaidya Sane Ayurved Laboratories Income Statement Screener - Profit & Revenue Analysis
Intrinsic ValueScreen MADHAVBAUG income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2023-Sept | 2023-Jun | 2022-Sept |
|---|---|---|---|
| Revenue | 5,173 | 4,641 | 10,053 |
| Expenses | 4,842 | 4,142 | 9,131 |
| EBITDA | 332 | 500 | 922 |
| Operating Profit % | 5.00% | 9.00% | 8.00% |
| Depreciation | 159 | 116 | 260 |
| Interest | 16 | 11 | 19 |
| Profit Before Tax | 157 | 373 | 643 |
| Tax | -78 | 126 | -323 |
| Net Profit | 235 | 247 | 967 |
| EPS | 1.12 | 2.60 | 4.60 |
Vaidya Sane Ayurved Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen MADHAVBAUG cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2024-March | 2023-March |
|---|---|---|
| Operating Activities | -4 | 0 |
| Investing Activities | 2 | 1 |
| Financing Activities | 15 | -1 |
| Net Cash Flow | 12 | -1 |
Screen MADHAVBAUG shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Sept | 2025-Mar | 2024-Sept | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 66.34% | 66.34% | 66.34% | 66.34% | 66.34% | 66.34% | 66.34% | 66.34% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 21.80% | 21.94% | 22.24% | 22.69% | 22.31% | 22.92% | 23.90% | 24.24% |
| Other Holding | 11.86% | 11.72% | 11.43% | 10.97% | 11.35% | 10.74% | 9.76% | 9.42% |
| Shareholder Count | 712 | 787 | 821 | 881 | 846 | 731 | 637 | 595 |
Vaidya Sane Ayurved Laboratories Dividend Screener - Share Yield Analysis
Screen MADHAVBAUG dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.25 | 0.14% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Vaidya Sane Ayurved Laboratories Index Membership - Market Screener Classification
Screen MADHAVBAUG by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Vaidya Sane Ayurved Laboratories Market Events Screener - Corporate Actions
Screen MADHAVBAUG market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 0.25 /share | 37.01% | ||
| Annual General Meeting | NA | -1.37% | ||
| 2025-11-05 | 2025-11-05 | Quarterly Result Announcement | NA | -0.53% |
| 2025-08-25 | 2025-08-25 | Extraordinary General Meeting | NA | 23.93% |
| 2025-05-22 | 2025-05-22 | Quarterly Result Announcement | NA | 5.65% |
| 2024-11-11 | 2024-11-11 | Quarterly Result Announcement | NA | 12.48% |
| 2022-11-18 | 2022-11-18 | Dividend | ₹ 0.25 /share | 6.63% |
Vaidya Sane Ayurved Laboratories Competitors Screener - Peer Comparison
Screen MADHAVBAUG competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Poly Medicure | 17,938 | 48.86 | 1,759 | 22.62% | 339 | 41.94 |
| Laxmi Dental | 1,489 | 58.15 | 242 | 24.12% | 25 | 48.24 |
| Tarsons Products | 1,252 | 60.61 | 408 | 32.64% | 30 | 50.37 |
| Osel Devices | 974 | 49.03 | 187 | 40.62% | 20 | 38.77 |
| Vasa Denticity | 970 | 64.98 | 173 | 43.89% | 15 | 37.67 |
| Fabtech Technologies | 881 | 18.64 | 336 | 45.66% | 47 | 34.08 |
| Aprameya Engineering | 575 | 35.59 | 136 | 107.77% | 16 | 42.79 |
| Prevest Denpro | 573 | 28.71 | 67 | 13.15% | 18 | 50.22 |
| Hemant Surgical Industries | 380 | 47.95 | 112 | % | 8 | 50.50 |
| Nureca | 303 | 76.07 | 122 | 19.24% | 1 | 58.82 |
Vaidya Sane Ayurved Laboratories Company Announcements - News Screener
Screen MADHAVBAUG latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.